1. Academic Validation
  2. SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53

SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53

  • PLoS One. 2010 Oct 21;5(10):e13502. doi: 10.1371/journal.pone.0013502.
Cian J Lynch 1 Zahid H Shah Simon J Allison Shafiq U Ahmed Jack Ford Lorna J Warnock Han Li Manuel Serrano Jo Milner
Affiliations

Affiliation

  • 1 YCR p53 Research Unit, Department of Biology, University of York, York, United Kingdom. [email protected]
Abstract

Background: The NAD-dependent deacetylase SIRT1 is a nutrient-sensitive coordinator of stress-tolerance, multiple homeostatic processes and healthspan, while p53 is a stress-responsive transcription factor and our paramount tumour suppressor. Thus, SIRT1-mediated inhibition of p53 has been identified as a key node in the common biology of Cancer, metabolism, development and ageing. However, precisely how SIRT1 integrates such diverse processes remains to be elucidated.

Methodology/principal findings: Here we report that SIRT1 is alternatively spliced in mammals, generating a novel SIRT1 isoform: SIRT1-ΔExon8. We show that SIRT1-ΔExon8 is expressed widely throughout normal human and mouse tissues, suggesting evolutionary conservation and critical function. Further studies demonstrate that the SIRT1-ΔExon8 isoform retains minimal deacetylase activity and exhibits distinct stress sensitivity, RNA/protein stability, and protein-protein interactions compared to classical SIRT1-Full-Length (SIRT1-FL). We also identify an auto-regulatory loop whereby SIRT1-ΔExon8 can regulate p53, while in reciprocal p53 can influence SIRT1 splice variation.

Conclusions/significance: We characterize the first alternative isoform of SIRT1 and demonstrate its evolutionary conservation in mammalian tissues. The results also reveal a new level of inter-dependency between p53 and SIRT1, two master regulators of multiple phenomena. Thus, previously-attributed SIRT1 functions may in fact be distributed between SIRT1 isoforms, with important implications for SIRT1 functional studies and the current search for SIRT1-activating therapeutics to combat age-related decline.

Figures